Biomedical Engineering Reference
In-Depth Information
disease: an open label, phase I trial. Lancet
369:2097-2105
108. Eberling JL et al (2008) Results from a phase
I safety trial of hAADC gene therapy for
Parkinson disease. Neurology 70:1980-1983
108. Bobo RH et al (1994) Convection-enhanced
delivery of macromolecules in the brain. Proc
Natl Acad Sci 91:2076-2080
110. van der Bom IMJ et al (2013) Frameless mul-
timodal image guidance of localized
convection-enhanced delivery of therapeutics
in the brain. J Neurointerv Surg 5:69-72
111. Yin D et al (2010) Cannula placement for
effective convection-enhanced delivery in the
nonhuman primate thalamus and brainstem:
implications for clinical delivery of therapeu-
tics. J Neurosurg 113:240-248
112. White E et al (2011) A robust MRI-compatible
system to facilitate highly accurate stereotactic
administration of therapeutic agents to targets
within the brain of a large animal model. J
Neurosci Methods 195:78-87
113. Krauze MT et al (2005) Real-time visualiza-
tion and characterization of liposomal delivery
into the monkey brain by magnetic resonance
imaging. Brain Res Protoc 16:20-26
114. Subramanian T et al (2005) MRI guidance
improves accuracy of stereotaxic targeting for
cell transplantation in parkinsonian monkeys.
Exp Neurol 193:172-180
Search WWH ::
Custom Search